The activation of SIRT1 by resveratrol reduces breast cancer metastasis to lung through inhibiting neutrophil extracellular traps
Author:
Affiliation:
1. Department of Oncology, Shanghai Fourth People’s Hospital, Tongji University School of Medicine, Shanghai, China
2. Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Funder
Shanghai Fourth People’s Hospital
Hongkou District Health Committee of Shanghai
Wu Jieping Medical Foundation
Publisher
Informa UK Limited
Subject
Pharmaceutical Science
Link
https://www.tandfonline.com/doi/pdf/10.1080/1061186X.2023.2265585
Reference66 articles.
1. Cancer statistics for the US Hispanic/Latino population, 2021
2. Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer
3. Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
4. Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study
5. Clinical Characteristics and Treatment of Immune-Related Adverse Events of Immune Checkpoint Inhibitors
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. How neutrophils shape the immune response of triple-negative breast cancer: Novel therapeutic strategies targeting neutrophil extracellular traps;Biomedicine & Pharmacotherapy;2024-09
2. Programmed Cell Death-Related Gene Signature Associated with Prognosis and Immune Infiltration and the Roles of HMOX1 in the Proliferation and Apoptosis were Investigated in Uveal Melanoma;Genes & Genomics;2024-05-20
3. Targeting the breast tumor microenvironment by plant-derived products and their nanoformulations;Journal of Drug Delivery Science and Technology;2024-03
4. Identification of anti-gastric cancer effects and molecular mechanisms of resveratrol: From network pharmacology and bioinformatics to experimental validation;World Journal of Gastrointestinal Oncology;2024-02-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3